Navigation Links
Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL
Date:12/9/2008

herapy and after interruption of therapy for 7 or more days.
  • Infections: Serious, including fatal, bacterial, viral, fungal, and protozoan infections can occur in patients receiving Campath. Administer prophylaxis against Pneumocystis jiroveci pneumonia (PCP) and herpes virus infections.
  • Campath is indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). Campath is administered as an IV infusion over two hours and should be dose escalated to recommended dose of 30 mg/day three times per week for 12 weeks. Patients are premedicated with oral antihistamine and acetaminophen prior to dosing. The most commonly reported adverse reactions are infusion reactions (fever, chills, hypotension, urticaria, nausea, rash, tachycardia, dyspnea), cytopenias (neutropenia, lymphopenia, thrombocytopenia, anemia), and infections (CMV viremia, CMV infection, other infections). In clinical trials, the frequency of infusion reactions was highest in the first week of treatment. Other commonly reported adverse reactions include vomiting, abdominal pain, insomnia and anxiety. The most commonly reported serious adverse reactions are cytopenias, infusion reactions, and immunosuppression/infections. See "Warnings and Precautions," and "Adverse Reactions" sections of full Prescribing Information.

    About Bayer HealthCare Pharmaceuticals Inc.

    Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals operation of Bayer HealthCare, an affiliate of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, General Med
    '/>"/>

    SOURCE Bayer HealthCare Pharmaceuticals Inc.
    Copyright©2008 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. ViroPharma to Present at Three Upcoming Healthcare Conferences
    2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
    3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
    4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
    5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
    6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
    7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
    8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
    9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
    10. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
    11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
    (Date:8/28/2015)... 2015  With the heroin epidemic in ... Jacksonville -based Lakeview Health drug and alcohol ... to explain why fentanyl is causing a new wave ... times more potent than pharmaceutical grade heroin and often ... risk of death skyrockets. "Fentanyl can be ...
    (Date:8/28/2015)... Aug. 28, 2015  Delays in the launch ... slow down the decision-making process, resulting in missed ... critical for biopharmaceutical companies to develop a tactical ... for quicker and more meaningful insights. ... LLC, nearly three-quarters of benchmarked study participants use ...
    Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Expediting the Pharmaceutical Market Research Process for Faster Insights 2
    ... Therapeutics (NYSE Amex: CXM ) today ... a topically applied formulated collagen wound management gel ... factor (PDGF) locally at the wound site.  This ... essential role in the wound healing process. ...
    ... Prime Therapeutics (Prime), a thought leader in ... awarded full Pharmacy Benefit Management (PBM) accreditation from ... that establishes quality standards for the health care ... URAC accreditation in 2007, and has also achieved ...
    Cached Medicine Technology:Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 2Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 3Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 4Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 5Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 6Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process 7Prime Therapeutics Announces URAC Accreditation 2
    (Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... to insufficient scrotal support and protection against dribbled urine and sweat. "In order ... Manhasset Hills, N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal ...
    (Date:8/29/2015)... Aliso Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Cut Pro X . Each preset contains 15 seconds of unique footage that users ... presets that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, ...
    (Date:8/28/2015)... ... 29, 2015 , ... Rio Salado College joined nine educational institutions ... part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded ... Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is designed to ...
    (Date:8/28/2015)... Angeles, CA (PRWEB) , ... August 28, 2015 , ... ... endless journey that local pizza maker Paul LaRocco has gone through to open a ... city approval and permitting process tends to take several months, but the current process, ...
    (Date:8/28/2015)... ... 2015 , ... The 6th Annual Survivor in the City, Chicago silent ... another accolade to its cadre of widespread support—an official letter of support and gratitude ... the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, the ...
    Breaking Medicine News(10 mins):Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3
    ... percent of US adults have never had sex in their ... case of Mexican-Americans, according to an official survey out on ... years have had sex, with the age group 20-29 having ... and Prevention (CDC) said in a report. ,Eighty-eight percent ...
    ... is taking heavy toll of the US. Time something is ... Where does one cross the line? These are always problematic ... ,Unrestrained hedonism could pose serious public health threats, observers in ... of U.S. adults are virgins and a fifth have tried ...
    ... the European Union (EU) Parliament's resolution to ban mercury trade ... do likewise. ,Toxics Link and other green ... group had called upon governments across the world to ban ... (UNEP) in February. ,In one of its ...
    ... State University professors, Volodymyr Tarabara and Tom Voice, are ... . ,Tarabara and Voice are leading an international ... research universities, two research centers in France, and three ... technologies for the project. ,With the biggest ...
    ... her growing years that doctors thought she had brain tumour . ... eight till she was 13, when her parents separated. ... stress of her parents troubled married life. ,The 19-year-old ... was all in her head, and though the memories werent great, ...
    ... will be traveling next week and during July will ... 18-year old Nicholas Tan Xue-Wei, who will soon depart ... research paper at The 2007 World Congress in ... 25 to 28, in Las Vegas. ,Before ...
    Cached Medicine News:Health News:US Observers Concerned Over Increasingly Permissive Atmosphere 2Health News:Two MSU Professors Spearhead International Water Project 2Health News:Two MSU Professors Spearhead International Water Project 3Health News:Singaporean Student to Present Stem Cell Research Paper at Conferences in US, UK 2
    ... Bard. The Hernia Repair CompanySM is pleased ... hernia repair - Bard Composix E/X mesh.,When ... it was the first ventral hernia repair ... Bard polypropylene mesh and ePTFE, in one ...
    ... Kugel Patch, which is constructed of a double ... a positioning pocket, which is used to guide ... other side is a barrier of ePTFE. The ... which causes the patch to spring open and ...
    ... introduction in 1958, Bard mesh has become ... are compared. Bard mesh was used by ... the "tension-free" hernia repair many years ago. ... and ideal" substance for permanent reinforcement of ...
    ... Bard Visilex mesh is the ... laparoscopic hernia repair. Visilex mesh directly ... laparoscopic procedures. More specifically, it delivers ... a flat profile after insertion through ...
    Medicine Products: